NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nuformix plc (LSE: NFX)

 
NFX Technical Analysis
5
As on 25th Nov 2024 NFX STOCK Price closed @ 0.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.27 & Strong Sell for SHORT-TERM with Stoploss of 0.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NFXSTOCK Price

Open 0.04 Change Price %
High 0.06 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.05 1 Month -0.01 -16.67
Volume 211119350 1 Year -0.23 -82.14
52 Week High 0.40 | 52 Week Low 0.05
 
LSE UK Most Active Stocks
CPX 0.17 21.43%
TRP 0.03 %
UKOG 0.02 0.00%
LLOY 54.66 0.44%
MSMN 0.04 0.00%
BZT 0.03 0.00%
NFX 0.05 0.00%
DKE 0.15 0.00%
NNN 0.09 50.00%
SYME 0.00 %
 
LSE UK Top Gainers Stocks
0YY7 20.40 280.60%
SSIF 18.50 208.33%
CGW 55.03 107.66%
0DNH 0.31 93.75%
CNN 65.00 85.71%
VENC 139.60 65.21%
0QQ7 0.58 56.76%
0UTC 0.41 51.85%
NNN 0.09 50.00%
NNN 0.09 50.00%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0L7R 0.29 -78.20%
 
 
NFX
Daily Charts
NFX
Intraday Charts
Whats New @
Bazaartrend
NFX
Free Analysis
 
NFX Important Levels Intraday
RESISTANCE0.09
RESISTANCE0.08
RESISTANCE0.07
RESISTANCE0.06
SUPPORT0.04
SUPPORT0.03
SUPPORT0.02
SUPPORT0.01
 
NFX Forecast November 2024
4th UP Forecast0.22
3rd UP Forecast0.17
2nd UP Forecast0.13
1st UP Forecast0.1
1st DOWN Forecast0
2nd DOWN Forecast-0.03
3rd DOWN Forecast-0.07
4th DOWN Forecast-0.12
 
NFX Weekly Forecast
4th UP Forecast0.20
3rd UP Forecast0.15
2nd UP Forecast0.12
1st UP Forecast0.09
1st DOWN Forecast0.01
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.05
4th DOWN Forecast-0.10
 
NFX Forecast2024
4th UP Forecast0.82
3rd UP Forecast0.57
2nd UP Forecast0.42
1st UP Forecast0.27
1st DOWN Forecast-0.17
2nd DOWN Forecast-0.32
3rd DOWN Forecast-0.47
4th DOWN Forecast-0.72
 
 
NFX Other Details
Segment EQ
Market Capital 7335952.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NFX Address
NFX
 
NFX Latest News
 
Your Comments and Response on Nuformix plc
 
NFX Business Profile
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. Its lead programs include NXP001, which is in Phase 1-ready stage for oncology supportive care; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. The company is also developing NXP004, which is in the research Phase for treating oncology. It also has an option agreement with Oxilio Ltd. for developing and exploiting NXP001 for the treatment of cancer. Nuformix plc was founded in 2008 and is based in London, the United Kingdom. Address: 60 Gracechurch Street, London, United Kingdom, EC3V 0HR
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service